Pfizer's Q4 Earnings Beat Estimates, Non-Covid Drugs Drive Sales

Pfizer (PFE) reported fourth-quarter 2024 adjusted earnings per share of 63 cents, which beat the Zacks Consensus Estimate of 48 cents per share. The company had recorded earnings of 10 cents per share in the year-ago quarter.Find the latest EPS estimates and surprises on Zacks Earnings Calendar. Revenues came in at $17.76 billion, up 22% from the year-ago quarter on a reported basis. Revenues reflected an operational increase of 21% and a positive currency impact of 1%. Total revenues also beat the Zacks C ...